|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01K 67/027 | |
| C07K 14/54 | |||
| C07K 14/535 |
| (11) | Number of the document | 3308641 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17184813.8 |
| Date of filing the European patent application | 2013-11-05 | |
| (97) | Date of publication of the European application | 2018-04-18 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-03 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261722437 P | 2012-11-05 | US |
| (72) |
FLAVELL, Richard, US
STROWIG, Till, DE
MANZ, Markus G., CH
BORSOTTI, Chiara, US
DHODAPKAR, Madhav, US
MURPHY, Andrew J., US
STEVENS, Sean, US
YANCOPOULOS, George D., US
|
| (73) |
Yale University,
Two Whitney Avenue, New Haven, CT 06510,
US
Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US Institute for Research in Biomedicine (IRB), Via Vincenzo Vela 6, 6501 Bellinzona, CH |
| (54) | IMMUNODEFICIENT, GENETICALLY MODIFIED RODENT AND METHODS OF USE THEREOF |
| IMMUNODEFICIENT, GENETICALLY MODIFIED RODENT AND METHODS OF USE THEREOF |